Doutor ao Vivo
Plataforma white-label de telemedicina para empresas de saúde realizarem teleatendimentos de forma prática e segura.
Plataforma white-label de telemedicina para empresas de saúde realizarem teleatendimentos de forma prática e segura.
Doutor ao Vivo is a health care startup based in Brazil, founded in 2019. It offers a white-label telemedicine platform for health companies to conduct teleconsultations conveniently and securely. The platform enables health insurance companies, clinics, and doctors to engage in telemedicine through video conferencing for teleconsultations, teleorientation, teleinterconsultation, and teletriage.
One of the standout features of Doutor ao Vivo is its white-label model, allowing the platform to be customized with the partner's name and logo. Additionally, it boasts seamless integration with other systems, a Picture-In-Picture plugin for the consultation room, intelligent triage, voice transcribed medical reports, and email prescription delivery. The platform complies with current legislation and market security protocols.
The latest funding round for Doutor ao Vivo occurred on 23 June 2023, with Bossa Invest as the venture round investor. This investment signifies confidence in Doutor ao Vivo's potential to revolutionize the telemedicine industry and cater to the evolving needs of the health care sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | Unknown | 1 | Bossanova Investimentos | 23 Jun 2023 |
| Angel Round | $100.00K | 1 |
|
20 Nov 2021 |
No recent news or press coverage available for Doutor ao Vivo.
We care about your data, and we'd love to use cookies make your experience better.
